Literature DB >> 18980978

Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.

Susan K Lutgendorf1, Donald M Lamkin, Nicholas B Jennings, Jesusa M G Arevalo, Frank Penedo, Koen DeGeest, Robert R Langley, Joseph A Lucci, Steve W Cole, David M Lubaroff, Anil K Sood.   

Abstract

PURPOSE: Stromal cells in the tumor microenvironment, such as macrophages, play an active role in tumor growth and angiogenesis. However, little is known about relationships of biobehavioral factors with angiogenic cytokines and matrix metalloproteinases (MMP) produced by stromal cells. This study examined distress, MMPs, and angiogenic cytokines in ovarian cancer patients and in vitro. EXPERIMENTAL
DESIGN: Patients suspected of ovarian cancer completed preoperative questionnaires. At surgery, 56 were confirmed to have epithelial ovarian cancer. Tumor samples were analyzed for macrophage (CD68(+)) and tumor cell levels of MMP-2, MMP-9, and vascular endothelial growth factor. In vitro stimulation of isolated macrophage cells by the stress hormones norepinephrine and cortisol was done to assess effects on MMP-9.
RESULTS: Depressed patients showed significant elevations of MMP-9 in CD68(+) cells, adjusting for stage (P<0.0001). Patients with higher levels of current stress (P=0.01), life stress over the last 6 months (P=0.004), and general negative affect (P=0.007) also showed significantly greater MMP-9 in CD68(+) cells. In contrast, higher social support was associated with lower levels of MMP-9 (P=0.023) and vascular endothelial growth factor (P=0.036) in tumor cells. In vitro analyses showed that macrophage MMP-9 production could be directly enhanced (up to a 2-fold increase) by the stress hormones norepinephrine and cortisol.
CONCLUSIONS: Ovarian cancer patients with elevated depressive symptoms, chronic stress, and low social support showed elevations in MMP-9 in tumor-associated macrophages. Direct in vitro enhancement of stromal MMP-9 production by stress hormones was also shown. These findings may have implications for patient outcomes in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980978      PMCID: PMC2716059          DOI: 10.1158/1078-0432.CCR-08-0230

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  44 in total

1.  Contribution of differently localized alpha 2- and beta-adrenoceptors in the modulation of TNF-alpha and IL-10 production in endotoxemic mice.

Authors:  J Szelényi; J P Kiss; E Puskás; M Szelényi; E S Vizi
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Present concepts on the inflammatory modulators with special reference to cytokines.

Authors:  A S J P A M Van Miert
Journal:  Vet Res Commun       Date:  2002-02       Impact factor: 2.459

Review 3.  Stress and the inflammatory response: a review of neurogenic inflammation.

Authors:  Paul H Black
Journal:  Brain Behav Immun       Date:  2002-12       Impact factor: 7.217

4.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

Authors:  G Bergers; R Brekken; G McMahon; T H Vu; T Itoh; K Tamaki; K Tanzawa; P Thorpe; S Itohara; Z Werb; D Hanahan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

Review 5.  Modulation of the vascular endothelium during infection--the role of NF-kappa B activation.

Authors:  Angelika Bierhaus; Peter P Nawroth
Journal:  Contrib Microbiol       Date:  2003

6.  Depressive symptoms predict norepinephrine response to a psychological stressor task in Alzheimer's caregivers.

Authors:  Brent T Mausbach; Joel E Dimsdale; Michael G Ziegler; Paul J Mills; Sonia Ancoli-Israel; Thomas L Patterson; Igor Grant
Journal:  Psychosom Med       Date:  2005 Jul-Aug       Impact factor: 4.312

7.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.

Authors:  Suyun Huang; Melissa Van Arsdall; Sean Tedjarati; Marya McCarty; Wenjuan Wu; Robert Langley; Isaiah J Fidler
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

8.  Vascular endothelial growth factor and social support in patients with ovarian carcinoma.

Authors:  Susan K Lutgendorf; Erica L Johnsen; Brian Cooper; Barrie Anderson; Joel I Sorosky; Richard E Buller; Anil K Sood
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

9.  Stress-related modulation of matrix metalloproteinase expression.

Authors:  Eric V Yang; Cynthia M Bane; Robert C MacCallum; Janice K Kiecolt-Glaser; William B Malarkey; Ronald Glaser
Journal:  J Neuroimmunol       Date:  2002-12       Impact factor: 3.478

Review 10.  Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity.

Authors:  Ilia J Elenkov; George P Chrousos
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

View more
  66 in total

Review 1.  Biobehavioral factors and cancer progression: physiological pathways and mechanisms.

Authors:  Susan K Lutgendorf; Anil K Sood
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

Review 2.  Neuroendocrine influences on cancer progression.

Authors:  Guillermo N Armaiz-Pena; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Brain Behav Immun       Date:  2012-06-21       Impact factor: 7.217

Review 3.  Host factors and cancer progression: biobehavioral signaling pathways and interventions.

Authors:  Susan K Lutgendorf; Anil K Sood; Michael H Antoni
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 4.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 5.  Neural regulation of hematopoiesis, inflammation, and cancer.

Authors:  Maher Hanoun; Maria Maryanovich; Anna Arnal-Estapé; Paul S Frenette
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

6.  Stressing the need to overcome EGFR tyrosine kinase inhibitor resistance.

Authors:  Leila Toulabi; Bríd M Ryan
Journal:  Transl Lung Cancer Res       Date:  2018-04

7.  Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer.

Authors:  Devika R Jutagir; Bonnie B Blomberg; Charles S Carver; Suzanne C Lechner; Kiara R Timpano; Laura C Bouchard; Lisa M Gudenkauf; Jamie M Jacobs; Alain Diaz; Susan K Lutgendorf; Steve W Cole; Aaron S Heller; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

8.  Impact of cardiovascular comorbidity on ovarian cancer mortality.

Authors:  Eileen H Shinn; Daniel J Lenihan; Diana L Urbauer; Karen M Basen-Engquist; Alan Valentine; Laura Palmero; Myrshia L Woods; Pooja Patel; Alpa M Nick; Mian M K Shahzad; Rebecca L Stone; Antoinette Golden; Emma Atkinson; Susan K Lutgendorf; Anil K Sood
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

9.  Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression.

Authors:  Jason Tilan; Joanna Kitlinska
Journal:  J Oncol       Date:  2010-05-20       Impact factor: 4.375

10.  Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Premal H Thaker; Jesusa M Arevalo; Michael J Goodheart; George M Slavich; Anil K Sood; Steve W Cole
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.